All news

• Revenue up 4% • Improved results • Stronger growth potential

In the final quarter of 2025, Spineway, a specialist in innovative implants for the treatment of severe spine disorders, benefited from an acceleration in sales across all of its markets and the receipt of key account orders deferred from the first half of the year. With revenue of €3.8 million, up 34% compared with Q4 2024 (€2.8 million), Spineway recorded a particularly dynamic fourth quarter.

Spineway will participate in the practical workshop on lumbar arthroplasty via retropersitoneal approach, organized by the French Society for Spine Surgery (SFCR) on Friday, February 27, 2026, in Amiens, at the Anatomy and Organogenesis Laboratory of the Faculty of Medicine.

Spineway will participate in the 2026 Congress of the French Spine Surgery Society (SFCR), which will be held from June 11 to 13 at the Palais du Pharo in Marseille.

Spineway will participate in the EUROSPINE 2026 congress, which will be held from October 7 to 9, 2026, in Gothenburg, Sweden.

Spineway, a specialist in innovative implants for the treatment of spine disorders, announces the commercial launch of its VEOS and Twin Peaks ranges in Colombia.

Spineway, a specialist in innovative implants for the treatment of severe spine disorders, announces that it has conducted several training sessions for surgeons in Europe and Asia, confirming its commitment to helping practitioners master its innovative solutions.